悦康药业
(688658)
| 流通市值：55.44亿 | | | 总市值：55.44亿 |
| 流通股本：4.50亿 | | | 总股本：4.50亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,181,150,785.77 | 556,037,071.94 | 2,446,086,968.93 | 1,759,106,131.97 |
| 营业总成本 | 1,224,055,531.32 | 582,235,968.13 | 2,682,131,403.61 | 1,936,291,861.68 |
| 其他经营收益 | | | | |
| 营业利润 | -99,104,324.44 | -29,955,382.27 | -234,445,723.9 | -163,702,962.86 |
| 利润总额 | -101,784,847 | -30,561,847.59 | -237,052,455.85 | -164,811,303.27 |
| 净利润 | -120,440,561.9 | -38,027,504.61 | -274,816,190.81 | -154,602,737.51 |
| 每股收益 | | | | |
| 其他综合收益 | -8,018.42 | - | -28,239.37 | - |
| 综合收益总额 | -120,448,580.32 | -33,106,026.51 | -274,844,430.18 | -154,602,737.51 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,473,271,203.84 | 2,518,471,299.95 | 2,589,168,333.82 | 2,528,719,010.98 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,575,936,271.01 | 2,668,679,378.71 | 2,610,403,304.87 | 2,700,983,923.05 |
| 资产总计 | 5,049,207,474.85 | 5,187,150,678.66 | 5,199,571,638.69 | 5,229,702,934.03 |
| 流动负债: | | | | |
| 流动负债合计 | 1,249,532,518.29 | 1,277,090,700.77 | 1,677,302,227.17 | 1,375,169,644.44 |
| 非流动负债: | | | | |
| 非流动负债合计 | 609,911,291.43 | 637,879,722.07 | 212,057,166.07 | 424,079,351.47 |
| 负债合计 | 1,859,443,809.72 | 1,914,970,422.84 | 1,889,359,393.24 | 1,799,248,995.91 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,210,304,927.85 | 3,282,101,354.88 | 3,315,211,866.41 | 3,429,651,990.12 |
| 股东权益合计 | 3,189,763,665.13 | 3,272,180,255.82 | 3,310,212,245.45 | 3,430,453,938.12 |
| 负债和股东权益合计 | 5,049,207,474.85 | 5,187,150,678.66 | 5,199,571,638.69 | 5,229,702,934.03 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,247,994,646.17 | 624,869,112.03 | 3,050,668,394.32 | 2,099,678,821.16 |
| 经营活动现金流出小计 | 1,238,474,729.53 | 580,398,861.03 | 2,710,381,829.9 | 1,931,344,531.58 |
| 经营活动产生的现金流量净额 | 9,519,916.64 | 44,470,251 | 340,286,564.42 | 168,334,289.58 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 363,627,926.89 | 293,115,315.68 | 634,417,970.48 | 322,333,602.09 |
| 投资活动现金流出小计 | 716,363,146.81 | 531,830,420.17 | 1,104,080,502.09 | 723,921,992.41 |
| 投资活动产生的现金流量净额 | -352,735,219.92 | -238,715,104.49 | -469,662,531.61 | -401,588,390.32 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 512,000,000 | 489,500,000 | 122,623,831.62 | 128,688,063.9 |
| 筹资活动现金流出小计 | 507,650,441.79 | 482,992,503.85 | 234,678,349.28 | 152,003,952.17 |
| 筹资活动产生的现金流量净额 | 4,349,558.21 | 6,507,496.15 | -112,054,517.66 | -23,315,888.27 |
| 汇率变动对现金及现金等价物的影响 | -262,694.12 | -64,600.84 | 137,936.78 | 169,760.33 |
| 现金及现金等价物净增加额 | -339,128,439.19 | -187,801,958.18 | -241,292,548.07 | -256,400,228.68 |
| 期末现金及现金等价物余额 | 657,398,153.54 | 808,724,634.55 | 996,526,592.73 | 981,418,912.12 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -339,128,439.19 | - | -241,292,548.07 | - |
最新报告期：2026-08-24| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 开源证券 | 余汝意,巢舒然 | -0.14 | 0.03 | 0.19 | 2026-08-24 |